Cargando…

Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer

Platinum-based adjuvant chemotherapy improves survival among patients with lung tumors, in particular non-small cell lung cancer (NSCLC). But the predicament of drug resistance in NSCLC patients is frustrating us. The profiles of microRNAs are different between platinum chemotherapy resistant and se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Hongjing, Peng, Jianlun, Wang, Weiyuan, Fan, Songqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688939/ https://www.ncbi.nlm.nih.gov/pubmed/29151973 http://dx.doi.org/10.7150/jca.21267

Ejemplares similares

Long non-coding RNAs associated with non-small cell lung cancer
por: Zhan, Yuting, et al.
Publicado: (2017)

MicroRNAs associated with therapy of non-small cell lung cancer
por: Lu, Junmi, et al.
Publicado: (2018)

Expression of WDR79 is associated with TP53 mutation and poor prognosis in surgically resected non-small cell lung cancer
por: Peng, Jinwu, et al.
Publicado: (2019)

YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer
por: Ning, Yue, et al.
Publicado: (2023)

miR-4634 augments the anti-tumor effects of RAD001 and associates well with clinical prognosis of non-small cell lung cancer
por: Liu, Sile, et al.
Publicado: (2020)

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
por: Wen, Qiuyuan, et al.
Publicado: (2019)

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017)

CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway
por: Wen, Qiuyuan, et al.
Publicado: (2016)

Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
por: Biersack, Bernhard
Publicado: (2016)

Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy
por: Papadaki, Chara, et al.
Publicado: (2020)

Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
por: Sin, Thomas K., et al.
Publicado: (2016)

Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer
por: Pal, A.S., et al.
Publicado: (2020)

Exosomal microRNAs in non-small cell lung cancer
por: Duréndez-Sáez, Elena, et al.
Publicado: (2021)

Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer
por: Liu, Sile, et al.
Publicado: (2022)

Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer
por: Tanabe, Shihori, et al.
Publicado: (2023)

Comprehensive analysis of aberrantly expressed long non-coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer
por: Chen, Peng, et al.
Publicado: (2020)

AXL in cancer: a modulator of drug resistance and therapeutic target
por: Tang, Yaoxiang, et al.
Publicado: (2023)

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
por: Shen, Jun, et al.
Publicado: (2011)

Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer
por: Ahn, Young-Ho, et al.
Publicado: (2020)

Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer
por: Le, Mai Thi, et al.
Publicado: (2023)

Prognostic value of microRNAs in lung cancer: A systematic review and meta-analysis
por: Xiao, Wendi, et al.
Publicado: (2019)

Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer
por: Tang, Yaoxiang, et al.
Publicado: (2022)

Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
por: Liu, Qingyun, et al.
Publicado: (2016)

Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer
por: Chen, Bo, et al.
Publicado: (2019)

Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands
por: Hassanein, Sarah Sayed, et al.
Publicado: (2021)

MicroRNAs in Epithelial–Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy
por: Peng, Fu, et al.
Publicado: (2021)

Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2018)

MicroRNAs in lung cancer
por: Castro, Diana, et al.
Publicado: (2017)

Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer
por: WANG, YADI, et al.
Publicado: (2016)

MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going
por: Cuttano, Roberto, et al.
Publicado: (2022)

Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer
por: Wozniak, Magdalena B., et al.
Publicado: (2015)

Hyperprogression After Immune-Checkpoint Inhibitor Treatment: Characteristics and Hypotheses
por: Zang, Hongjing, et al.
Publicado: (2020)

Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer
por: Geng, Qing, et al.
Publicado: (2014)

Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer
por: Chen, Yixin, et al.
Publicado: (2023)

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
por: Konoshenko, Maria, et al.
Publicado: (2022)

Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients
por: Tang, Yaoxiang, et al.
Publicado: (2021)

Small RNA sequencing of exosomal microRNAs reveals differential expression of microRNAs in preeclampsia
por: Ning, Hui, et al.
Publicado: (2023)

MicroRNAs-Role in Lung Cancer
por: Guz, Małgorzata, et al.
Publicado: (2014)

Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer
por: Lu, Junmi, et al.
Publicado: (2020)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
por: Lin, H-M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7p85p9kofgd5016gms5rnbg71n